Vimentin expression status is a potential biomarker for brain metastasis development in EGFR-mutant NSCLC patients

BACKGROUND: Despite advances in systemic therapy and improvements in survival for advanced epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC), brain metastasis (BM) remains a poor outcome. Previous studies on risk factors for BM occurrence included unselected patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Teocharoen, Rattanawadee, Ruangritchankul, Komkrit, Vinayanuwattikun, Chanida, Sriuranpong, Virote, Sitthideatphaiboon, Piyada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947392/
https://www.ncbi.nlm.nih.gov/pubmed/33718022
http://dx.doi.org/10.21037/tlcr-20-1020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947392/
https://www.ncbi.nlm.nih.gov/pubmed/33718022
http://dx.doi.org/10.21037/tlcr-20-1020

Ejemplares similares